Equity

AOCI

Medtronic AOCI decreased by 1.3% to -$4.33B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 52.5%, from -$2.84B to -$4.33B. Over 4 years (FY 2021 to FY 2025), AOCI shows a downward trend with a 5.3% CAGR.

Analysis

StatementBalance Sheet Statement
SectionEquity
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ4 2014
Last reportedQ3 2026Feb 24, 2026

How to read this metric

Fluctuations often signal changes in foreign exchange rates, interest rate environments, or pension funding status.

Detailed definition

Accumulated Other Comprehensive Income (AOCI) captures the cumulative unrealized gains and losses that are excluded from...

Peer comparison

Standard equity component for large multinational corporations with complex balance sheets.

Metric ID: aoci

Historical Data

20 periods
 Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Value-$3.49B-$3.21B-$3.04B-$2.88B-$2.27B-$1.94B-$2.36B-$3.19B-$3.50B-$3.67B-$3.38B-$3.46B-$3.32B-$3.41B-$3.25B-$2.84B-$4.28B-$4.60B-$4.28B-$4.33B
QoQ Change+7.9%+5.2%+5.4%+21.3%+14.4%-21.8%-35.1%-9.7%-5.0%+8.1%-2.4%+4.1%-2.8%+4.7%+12.6%-50.9%-7.5%+7.1%-1.3%
YoY Change+35.0%+39.6%+22.4%-10.8%-54.5%-89.5%-43.0%-8.5%+5.2%+7.2%+3.8%+17.9%-29.1%-35.0%-31.5%-52.5%
Range-$4.60B-$1.94B
CAGR+4.7%
Avg YoY Growth-14.0%
Median YoY Growth-9.6%

Frequently Asked Questions

What is Medtronic's aoci?
Medtronic (MDT) reported aoci of -$4.33B in Q4 2025.
How has Medtronic's aoci changed year-over-year?
Medtronic's aoci decreased by 52.5% year-over-year, from -$2.84B to -$4.33B.
What is the long-term trend for Medtronic's aoci?
Over 4 years (2021 to 2025), Medtronic's aoci has grown at a 5.3% compound annual growth rate (CAGR), from -$3.49B to -$4.28B.
What does aoci mean?
The cumulative total of unrealized gains and losses not yet reflected in net income.